Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8481021 IL-1F5 polypeptides

Patent 8481021 was granted and assigned to Amgen on July, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Amgen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8481021

Patent Inventor Names

John E Sims0

Randal R Ketchem0

Blair R Renshaw0

Christopher Gabel0

Jennifer E. Towne0

Date of Patent

July 9, 2013

Patent Application Number

13225326

Date Filed

September 2, 2011

Patent Citations Received

‌

US Patent 11926665 Methods of treating cancer with anti-TIM-3 antibodies

‌

US Patent 11753472 Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3)

Patent Primary Examiner

‌

Ruixiang Li

Patent abstract

The present invention provides compositions and methods relating to IL-1Rrp2 requiring proteins.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8481021 IL-1F5 polypeptides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API